Related Experiment Videos
Bolus and continuous infusion of tolazoline in neonates with hypoxemia
Insights
Tolazoline hydrochloride was studied in neonates with hypoxemia. The tolazoline hydrochloride single dose plus infusion method showed more frequent initial improvement but also increased adverse events like hypotension.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Critical Care
Background:
- Hypoxemia is a critical condition in neonates.
- Tolazoline hydrochloride is a vasodilator used in neonatal care.
Purpose of the Study:
- To compare the efficacy and safety of two tolazoline hydrochloride administration methods in neonates with hypoxemia.
- To evaluate the impact of tolazoline hydrochloride on partial arterial oxygen pressure (PaO2) and survival rates.
Main Methods:
- Randomized assignment of 24 neonates with hypoxemia.
- Two groups: single dose (SD) of 2 mg/kg IV tolazoline hydrochloride vs. single dose plus continuous infusion (SDI) of 2 mg/kg/h.
- Monitoring of PaO2 and adverse events.
Main Results:
- Increased PaO2 (≥15 mm Hg within 20 min) was more frequent in the SDI group.
- Hypotension and gastrointestinal bleeding were more common in the SDI group.
- No significant difference in survival rates between the two administration methods.
Conclusions:
- The tolazoline hydrochloride single dose plus infusion regimen may improve initial oxygenation in neonates with hypoxemia.
- This enhanced regimen is associated with a higher incidence of adverse events.
- Tolazoline hydrochloride administration method did not correlate with survival outcomes.
Abstract:
We randomly assigned 24 neonates with hypoxemia to receive tolazoline hydrochloride. Thirteen received a single dose (SD) of 2 mg/kg intravenously, and 11 received a SD of 2 mg/kg plus a 2 mg/kg/h intravenous infusion (SDI). Increase in PaO2 greater than or equal to 15 mm Hg within 20 min of administration was more common in SDI patients. Hypotension and gastrointestinal bleeding occurred more often in SDI patients. Survival could not be related to the method of administration or initial relief of hypoxemia with tolazoline.